Furthermore, the application of a nanodrug containing miR-30a-5p has demonstrated the ability to suppress malignant characteristics of ocular melanoma through targeted interaction with E2F7, as observed in both laboratory and live settings [60]. The gene discussed is E2F7; the disease is ocular melanoma.